Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$28.19
0.100.36%
At close: Dec 10, 4:00 PM EST
$28.25
0.060.21%
After Hours: 4:31 PM EST
Comments
Loading...
Celldex Therapeutics (CLDX) Stock Price, Quote, News & History
CLDXNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Celldex Therapeutics (CLDX) stock?
You can purchase shares of Celldex Therapeutics (NASDAQ:CLDX) through any online brokerage.
Who are Celldex Therapeutics (CLDX) competitors?
Other companies in Celldex Therapeutics’s space includes: Immunome Inc (NASDAQ:IMNM), Twist Bioscience Corp (NASDAQ:TWST), Upstream Bio Inc (NASDAQ:UPB), Syndax Pharmaceuticals Inc (NASDAQ:SNDX) and NuCana PLC (NASDAQ:NCNA).
What is the forecast, or price target, for Celldex Therapeutics (CLDX) stock?
Celldex Therapeutics has a consensus price target of $48.00.
What is the current price for Celldex Therapeutics (CLDX)?
The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $28.25 last updated December 10, 2025 at 4:31 PM EST.
Does Celldex Therapeutics (CLDX) pay a dividend?
There are no upcoming dividends for Celldex Therapeutics.
When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?
Celldex Therapeutics does not have any upcoming earnings scheduled.
Is Celldex Therapeutics (CLDX) going to split?
There is no upcoming split for Celldex Therapeutics.
What sector and industry does Celldex Therapeutics (CLDX) operate in?
Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
